Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 65
Filter
1.
J Endocrinol Invest ; 47(2): 335-343, 2024 Feb.
Article in English | MEDLINE | ID: mdl-37458931

ABSTRACT

BACKGROUND: It is not clear whether changes in body composition induced by androgen deprivation therapy (ADT) in prostate cancer (PC) patients are uniform or vary in the different body districts and whether regional lean body mass (LBM) and fat body mass (FBM) could have an impact on bone health. OBJECTIVE: To prospectively evaluate the regional changes in LBM and FBM in PC patients submitted to degarelix; to explore the relationship of regional body composition and bone mineral density (BMD) and bone turnover markers. DESIGN, SETTING, AND PARTICIPANTS: 29 consecutive non metastatic PC patients enrolled from 2017 to 2019. FBM, LBM and bone mineral density (BMD) evaluated by dual-energy x-ray absorptiometry (DXA) at baseline and after 12-month of ADT. Alkaline phosphate (ALP) and C-terminal telopeptide of type I collagen (CTX) assessed at baseline, 6 and 12 months. INTERVENTION: All patients underwent degarelix administration. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: T-test or sign test and Pearson or Spearman test for continuous variables were used when indicated. RESULTS AND LIMITATIONS: Median percent increase in FBM ranged from + 14.5% in trunk to + 25.4% in the left leg after degarelix. LBM changes varied from + 2% in the trunk to - 4.9% in the right arm. LBM in both arms and legs and their variations after degarelix directly correlated with ALP and inversely correlated with CTX. Lean mass of limbs, trunk and legs significantly correlated with BMD of the hip, lean mass of the trunk significantly correlated with spine BMD. These are post-hoc analysis of a prospective study and this is the main limitation. CONCLUSIONS: an heterogeneous change in body composition among body district is observed after ADT and bone turnover is influenced by lean mass and its variation. A supervised physical activity is crucial to maintain general physical performance and preserving bone health.


Subject(s)
Prostatic Neoplasms , Male , Humans , Prostatic Neoplasms/drug therapy , Bone Density , Androgen Antagonists/adverse effects , Androgens , Prospective Studies , Body Composition , Absorptiometry, Photon
2.
Urology ; 129: 235, 2019 Jul.
Article in English | MEDLINE | ID: mdl-30959118

ABSTRACT

OBJECTIVE: To show how to perform a robot-assisted partial nephrectomy and bilateral pyelolithotomy in ectopic pelvic kidneys. This is a congenital abnormality of position and rotation1 frequently associated with urolithiasis.2 Renal cell carcinoma is a very rare event in pelvic kidneys.3,4 These 2 findings in the same patient could be a surgical challenge and whenever possible a "one stage" treatment is preferred. MATERIALS AND METHODS: A 44-year-old male with bilateral pelvic kidneys admitted because of left back pain. Abdominal CT scan showed a 17 mm stone in the left renal pelvis, a 12 mm stones in the right pelvis and a 34 × 27 mm right lower pole renal mass. A robotic surgery was indicated. Patient was placed in Trendelenburg position with ports configuration as for transperitoneal radical prostatectomy. The right kidney was firstly approached: after isolation of the ureter and suspension of the renal artery, a clampless partial nephrectomy was performed; then through a longitudinal pyelotomy the stone was extracted. To minimize the opening of the posterior peritoneum covering the left kidney, the site of the stone was identified by intraoperative ultrasound; then, through a longitudinal pyelotomy the stone was extracted. Given the watertight sutures and the lack of ureteral obstructions no pigtails ureteral catheters were inserted. A Jackson-Pratt drainage was placed through the inferior port. RESULTS: Consolle time was 190 minutes. Estimated Blood Loss (EBL) was 50 ml. No complications were reported. The drain was removed on the second postoperative day, assessed that creatinine dosage was equal to serum. The length of stay was 4 days. Histopathology showed a pT1a G2 clear cell renal cell carcinoma with negative surgical margins, while stones analysis was calcium oxalate. CONCLUSION: With the availability of robotic technology, the indications for minimally invasive surgery may be safely expanded to include concomitant morbidities in uncommon presentations.


Subject(s)
Kidney Pelvis/surgery , Laparoscopy/methods , Nephrectomy/methods , Nephrotomy/methods , Robotic Surgical Procedures/methods , Adult , Humans , Kidney Pelvis/abnormalities , Kidney Pelvis/diagnostic imaging , Male , Patient Positioning , Tomography, X-Ray Computed , Ultrasonography
4.
Rev. estomatol. Hered ; 18(2): 105-113, jul.-dic. 2008. tab, ilus
Article in Spanish | LILACS, LIPECS | ID: lil-559047

ABSTRACT

El objetivo de este estudio fue evaluar y comparar la adaptación marginal de restauraciones, confeccionadas con dos tipos de sistemas cerámicos: CEREC® inLab (VITA) e IPS Empress 2(Ivoclar-Vivadent), después de su cementación con cemento resinoso. Fueron tallados 20 premolares humanos con cavidad MOD inlay, reproducidos con silicona de adición, y obtenidos modelos en yeso tipo IV, sobre los cuales fueron confeccionados las restauraciones conforme alas recomendaciones de los fabricantes. Diez inlays con el sistema IPS Empress 2 y 10 inlays con el sistema CEREC® inLab. Las restauraciones fueron cementadas bajo presión constante de 1,5 Kgf por 10 min, con cemento resinoso. Las desadaptaciones marginales fueron evaluadas conMEB, con magnificación de 200x, en 50 puntos equidistantes. Las medias fueron analizadas por el método estadístico t de Student de muestras dependientes. Resultando en una diferencia estadísticamente significante entre las desadaptaciones marginales en el sistema IPS Empress (93,8 15,5μm), que se mostraron menores que en el sistema CEREC® inLab (114,4±10,6μm).Cuando se compararon las medias entre las caras proximales (116,51±21,85μm) y Oclusal(112,26±8,49μm) del sistema CEREC®InLab, y las caras proximales (87,12±27,98μm) y Oclusal(100,47±22,23μm) del sistema IPS Empress 2, se verificó que esos valores no difieren estadísticamente. En frente a esos resultados se concluyó que las medias obtenidas son aceptables clínicamente.


This study has the purpose to evaluate the marginal adaptation of two system of all-ceramic class II inlays: one of laboratory-made heat-pressed ceramics (IPS Empress 2) and the othercomputer-aided manufacturing (CEREC®inLab) after cementation with resin cement . Extracted human premolars were prepared to receive mesio occluso distal (MOD) ceramic inlays for 10 IPS Empress restorations and 10 CEREC®inLab restorations. The impression material used was a polivinilsyloxane addition silicone by the double impression technique. The impressions of prepared teeth were cast in type IV dental stone. The restorations were made following the manufacturer's recommendations. The inlays were luted on human premolars with resin cementin accordance with the manufacturer's recommended pre-treatment. The marginal gaps were investigated by scanning electron microscopy with magnification of 200X. The results wereanalyzed by t(Student) statistic test. The means marginal gap for IPS Empress 2 was 93.8±15.5μmsignificantly lower than 114.4±10.6μm calculated at the CEREC®inLab system. The gaps of the inlays at the occlusal margin and of the approximal margin showed no significantly differencesin two systems. It may be concluded that measurement value are clinically acceptable.


Subject(s)
Humans , Dental Marginal Adaptation , Cementation , Resin Cements , Inlays
5.
Minerva Endocrinol ; 33(4): 297-312, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18923367

ABSTRACT

This review describes the therapeutic approach of endocrine arterial hypertension in clinical practice. In mineralocorticoid-related hypertension, adrenalectomy is the treatment of choice for aldosterone-producing adenomas and monolateral primary aldosteronism, whereas pharmacologic blood pressure (BP) control is indicated for the other forms of primary aldosteronism such as bilateral adrenal hyperplasia. Spironolactone is the drug of choice, but intolerable side effects limit its use; amiloride or eplerenone are a valid alternative. If BP remains uncontrolled, angiotensin converting enzyme inhibitors (ACE-I), angiotensin II receptor antagonists (AII-RA) and calcium channel blockers (CCB) may be added. Hypertension accompanying Cushing's syndrome can be approached with surgery, but antihypertensive treatment both pre- and postoperative is required as well. Eplerenone, AII-RA and ACE-I are indicated, while peroxisome proliferator activated receptor upsilon agonists may help for the insulin resistance syndrome. Drugs that suppress steroidogenesis should be used with care because of their serious side effects. Subjects with catecholamine-dependent hypertension due to a neuroendocrine neoplasm need to undergo preoperative alpha-adrenergic blockade with phenoxybenzamine or doxazozine. When adequate alpha-adrenergic blockade is achieved, beta-adrenergic blockade with low dose propranolol may be added. If target BP is not achieved, CCB and/or metyrosine are indicated. Laparoscopic adrenalectomy is the procedure of choice for solitary intra-adrenal neoplasms <8 cm. Acute hypertensive crises that may occur before or during surgery should be treated intravenously with sodium nitroprusside, phentolamine, nicardipine or labetalol. For malignant neoplasms, chemo- and radiopharmaceutical therapy may be considered.


Subject(s)
Antihypertensive Agents/therapeutic use , Hypertension/drug therapy , Hypertension/etiology , Adrenal Gland Diseases/complications , Adrenal Gland Neoplasms/complications , Adrenalectomy , Angiotensin II Type 1 Receptor Blockers/therapeutic use , Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Blood Pressure/drug effects , Calcium Channel Blockers/therapeutic use , Diuretics/therapeutic use , Drug Therapy, Combination , Humans , Hyperaldosteronism/complications , Hypertension/surgery , Renin-Angiotensin System/drug effects , Treatment Outcome
6.
Minerva Endocrinol ; 33(2): 127-46, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18272953

ABSTRACT

Endocrine arterial hypertension (EAH) a condition in which hormone excess results in clinically significant hypertension is a rare cause of hypertension. However in the last years its prevalence has increased, mostly due to the improvement of diagnostic work-up. In clinical practice, hypertensive subjects with suspicion of EAH currently undergo hormonal screening of the renin-aldosterone and catecholamines and glucocorticoids excess. This paper reviews current understanding for earlier recognition of the main forms of EAH and discusses screening laboratory methods and localization techniques that have enhanced the clinician's ability to make the diagnosis of EAH. Primary aldosteronism (PA) has recently been recognised as the most frequent cause of EAH. The aldosterone to renin ratio (ARR) is a highly recommended screening test for PA. When ARR is increased, confirmatory tests as saline infusion or fludrocortisone suppression are required. Differential diagnosis of PA requires adrenal gland imaging by computed tomography (CT) or magnetic resonance imaging (MRI), biochemical testing of the aldosterone response to posture, and selective adrenal venous sampling to differentiate unilateral aldosterone-producing adenoma from bilateral hyperplasia. Hypertension is frequently found in endogenous Cushing's Syndrome (CS). Twenty-four-hour urinary free cortisol measurement is the gold standard for the diagnosis of CS, but it must be confirmed by the overnight dexamethasone suppression test. CT and MRI are the primary imaging studies to perform, while scintigraphy is a useful confirmatory method. The most specific and sensitive diagnostic test for catecholamine-producing neoplasms is determination of urinary metanephrine levels; the neoplasms can be located by CT, MRI and metaiodo-benzylguanidine scintigraphy.


Subject(s)
Hypertension/diagnosis , Hypertension/etiology , Adenoma/complications , Adrenal Gland Neoplasms/complications , Aldosterone/blood , Algorithms , Catecholamines/blood , Cushing Syndrome/complications , Diagnosis, Differential , Glucocorticoids/blood , Humans , Hydrocortisone/urine , Hyperaldosteronism/complications , Hyperaldosteronism/diagnosis , Hyperaldosteronism/etiology , Hypertension/blood , Hypertension/urine , Mass Screening , Renin/blood , Tomography, X-Ray Computed
7.
Acta Diabetol ; 44(3): 99-105, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17721747

ABSTRACT

The relationship between serum uric acid (SUA) and risk of coronary heart disease (CHD) mortality remains controversial, particularly in diabetic subjects. The aim of the present study is to evaluate whether SUA independently predicts CHD mortality in non-insulin-dependent elderly people from the general population and to investigate the interactions between SUA and other risk factors. Five hundred and eighty-one subjects aged >/=65 years with non-insulin-dependent diabetes mellitus were prospectively studied in the frame of the CArdiovascular STudy in the ELderly (CASTEL). Historical and clinical data, blood tests and 12-year fatal events were recorded. SUA as a continuous item was divided into tertiles and, for each tertile, adjusted relative risk (RR) with 95% confidence intervals (CI) was derived from multivariate Cox analysis. CHD mortality was predicted by SUA in a J-shaped manner. Mortality rate was 7.9% (RR 1.28, CI 1.05-1.72), 6.0% (reference tertile) and 12.1% (RR 1.76, CI 1.18-2.27) in the increasing tertiles of SUA, respectively, without any difference between genders. In diabetic elderly subjects, SUA independently predicts the risk of CHD mortality in a J-shaped manner.


Subject(s)
Coronary Disease/mortality , Diabetes Mellitus, Type 2/blood , Diabetic Angiopathies/mortality , Uric Acid/blood , Aged , Biomarkers/blood , Blood Glucose/metabolism , Cholesterol/blood , Coronary Disease/blood , Creatinine/metabolism , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/mortality , Diabetic Angiopathies/blood , Female , Humans , Lipids/blood , Male , Risk Factors
8.
J Hum Hypertens ; 21(12): 934-41, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17568753

ABSTRACT

The classification of arterial hypertension (HT) to define metabolic syndrome (MS) is unclear in that different cutoffs of blood pressure (BP) have been proposed. We evaluated the categorization of HT most qualified to define MS in relationship with coronary heart disease (CHD) mortality at a population level. A total of 3257 subjects aged > or =65 years were followed up for 12 years. MS was defined according to the criteria of the National Education Cholesterol Program using three different categories of HT: MS-1 (systolic blood pressure (SBP) > or =130 and diastolic blood pressure (DBP) > or =85 mm Hg), MS-2 (SBP > or =130 or DBP > or =85 mm Hg) and MS-3 (pulse pressure (PP) > or =75 mm Hg in men and > or =80 mm Hg in women). Gender-specific adjusted hazard ratio (HR) with 95% confidence intervals (CI) for CHD mortality was derived from Cox analysis in the three MS groups, both including and excluding antihypertensive treatment. In women with MS untreated for HT, the risk of CHD mortality was always significantly higher than in those without MS, independent of categorization; the HR of MS was 1.73 (CI 1.12-2.67) using MS-1, 1.75 (CI 1.10-2.83) using MS-2 and 2.39 (CI 3.71-1.31) using MS-3. In women with MS treated for HT, the HR of CHD mortality was significantly increased only in the MS-3 group (1.92, CI 1.1-2.88). MS did not predict CHD in men. In conclusion, MS can predict CHD mortality in elderly women with untreated HT but not in those with treated HT; in the latter, PP is the most predictive BP value.


Subject(s)
Hypertension/epidemiology , Metabolic Syndrome/epidemiology , Pulse , Aged , Alcohol Drinking/epidemiology , Antihypertensive Agents/therapeutic use , Blood Glucose/metabolism , Blood Pressure , Coronary Disease/epidemiology , Creatinine/metabolism , Female , Heart Rate , Humans , Hypertension/drug therapy , Italy/epidemiology , Lipids/blood , Longitudinal Studies , Pulmonary Disease, Chronic Obstructive/epidemiology , Uric Acid/blood , Ventricular Dysfunction, Left/epidemiology
9.
AJNR Am J Neuroradiol ; 28(4): 773-6, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17416837

ABSTRACT

BACKGROUND AND PURPOSE: After an early progression of signal intensity changes in T2-weighted MR images, also known as "neurofibromatosis bright objects," in patients with neurofibromatosis type 1 (NF-1), there is a tendency toward regression or even disappearance in early adulthood. The purpose of this study was to investigate whether adult patients with NF-1 exhibit generalized microstructural alterations even in normal-appearing brain regions. MATERIALS AND METHODS: Conventional and diffusion tensor MR imaging of the brain was obtained in 10 adult patients with NF-1 and 10 age-matched healthy volunteers. Apparent diffusion coefficient (ADC) and fractional anisotropy (FA) were measured in brain stem, basal ganglia, thalamus, corpus callosum, and frontal and parietooccipital white matter regions. RESULTS: Significantly increased ADC and decreased FA values were found in all regions of interest and in all patients with NF-1, irrespective of their scholastic achievement and subsequent professional performance, compared with control subjects (P < .001). There were no significant correlations with the age (P > .1) or with the lateralization between brain hemispheres (P > .05). CONCLUSION: Diffusion tensor imaging reveals globally elevated FA and decreased ADC values in the mature brains of patients with NF-1, which is most likely a consequence of diffuse and basic alterations in cerebral microstructure that result from the underlying gene mutation.


Subject(s)
Brain/pathology , Diffusion Magnetic Resonance Imaging , Neurofibromatosis 1/pathology , Adolescent , Adult , Anisotropy , Caudate Nucleus/pathology , Cerebral Cortex/pathology , Corpus Striatum/pathology , Female , Humans , Male , Thalamus/pathology
10.
Fungal Genet Biol ; 41(7): 688-97, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15275664

ABSTRACT

Truffles form a group of plant-symbiotic Ascomycetes whose hypogeous life cycle is poorly understood. Here we present initial evidence for the influence of light on Tuber borchii mycelial growth and the identification and cloning of a gene, Tbwc-1, homologous to a blue-light photoreceptor of Neurospora crassa. Blue-light irradiation of T. borchii colonies inhibits their apical growth. It also alters apical growth in N. crassa. In Neurospora, the response is controlled by a nuclear photoreceptor, NcWC-1 (White Collar-1), which consists of a sensor domain (LOV) and a transcriptional factor moiety. We isolated a gene (Tbwc-1) whose deduced amino acid sequence shows a high similarity and colinearity of domains with NcWC-1, except for the polyglutamine regions. As previously found in Neurospora, Tbwc-1 mRNA is under light control and its steady state level increases upon irradiation. In silico analysis of the TbWC-1 sensor domain (LOV) supports the hypothesis that TbWC-1 is a photoreceptor, while the absence of the two polyglutamine regions involved in transcriptional activation in Neurospora suggests that this function in Tuber could be lost.


Subject(s)
Ascomycota/growth & development , Ascomycota/genetics , DNA-Binding Proteins/genetics , Fungal Proteins/genetics , Transcription Factors/genetics , Amino Acid Sequence , Ascomycota/cytology , Cloning, Molecular , Conserved Sequence , DNA, Fungal/chemistry , DNA, Fungal/isolation & purification , DNA-Binding Proteins/chemistry , DNA-Binding Proteins/isolation & purification , Fungal Proteins/chemistry , Fungal Proteins/isolation & purification , Gene Expression Regulation, Fungal , Genes, Fungal , Light , Models, Molecular , Molecular Sequence Data , Morphogenesis , Mycelium/genetics , Mycelium/growth & development , Neurospora crassa/genetics , Photoreceptors, Microbial/genetics , Photoreceptors, Microbial/isolation & purification , Polyglutamic Acid/genetics , Protein Structure, Tertiary , RNA, Fungal/analysis , RNA, Messenger/analysis , Sequence Alignment , Sequence Homology, Amino Acid , Transcription Factors/chemistry , Transcription Factors/isolation & purification , Transcription, Genetic
11.
Int J Artif Organs ; 26(2): 105-12, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12653343

ABSTRACT

The main target for low flux hemodialyzers is an efficient low molecular weight solutes clearance. Such efficiency is largely dependent on the optimization of diffusion between blood and dialysis solution. The diffusion process can be impaired if there is a mismatch between blood and dialysate flow distribution in the dialyzer. Thus optimized flow distribution both in the blood and dialysate compartment becomes quintessential for the maximal efficiency of the diffusion process within the hemodialyzer. The present paper describes the distribution of the blood and dialysate flows in a new low flux polysulfone hollow fiber hemodialyzer characterized by a specific undulation of the fibers and a new cutting technology of the fibers for an improved micro-flow condition in the blood compartment headers. Twelve Diacap alpha Polysulfone LO PS 15 (1.5 sqm) (B. Braun Medizintechnologie, Melsungen Germany) were employed for the study. Six were analyzed in vitro and six were studied in vivo. Blood flow distribution was studied in vitro by dye injection in the blood compartment during experimental extracorporeal circulation utilizing human blood with hematocrit adjusted at 33%. Sequential images were obtained with a helical scanner in a fixed longitudinal section of the dialyzer 1 cm thick. Average and regional blood flow velocities were measured utilizing the reconstructed imaging sequence. The method allowed the calculation of single fiber blood flow (SF Qb) and the mass transfer zone (MTR) definition in digitally subtracted images. The patterns 20-10 and 40-30 were utilized. The same technology was used to evaluate flow distribution in the dialysate compartment after dye injection in the Hansen's connector. Regional dialysate flow was calculated in central and peripheral sample areas of 1 cm2. Six in vivo hemodialysis treatments on patients with end stage renal disease were performed at three different blood flow rates (250-350 and 450 ml/min) in order to measure urea, creatinine and phosphate clearance. Macroscopic and densitometrical analysis revealed that flow distribution was homogeneous in the blood compartment while in the dialysate compartment a slight difference between the peripheral and central regions in terms of flow velocity was observed. This however was not generating channeling phenomena. Urea creatinine and phosphate clearances were remarkably high and so were the Kt/V observed in all sessions, especially in relation to the studied blood flows. In conclusion, a significant blood to dialysate flow match with optimized countercurrent flow condition was observed in the studied hollow fiber hemodialyzers. Such optimization might be due both to the improved dialyzer design at the level of the blood header and to the specific fiber undulation that prevents dialysate channeling.


Subject(s)
Blood Flow Velocity , Dialysis Solutions/pharmacokinetics , Membranes, Artificial , Renal Dialysis/instrumentation , Biocompatible Materials/therapeutic use , Diffusion , Equipment Design , Humans , Kidney Failure, Chronic/therapy , Polymers/therapeutic use , Sulfones/therapeutic use
13.
Am J Hematol ; 64(3): 197-202, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10861816

ABSTRACT

A primary cutaneous form of peripheral T-cell lymphoma (PTCL) and a low grade B-cell non-Hodgkin's lymphoma that was classified as a variant of hairy cell leukemia (HCL) were simultaneously diagnosed in a 79-year-old woman by both phenotypic and genotypic analyses. The coexistence of a T- and B-cell lymphoma in the same patient is rare, and, to our knowledge, this particular association has not been previously described. The patient was referred to our Department for evaluation of multiple cutaneous itchy, reddish plaques; laboratory analyses disclosed a lymphocytosis, that presented 6 years earlier. A bone marrow aspirate showed a 50% B-cell interstitial infiltrate, while a skin biopsy surprisingly revealed a PTCL. Clonality of both neoplastic processes was assessed by Southern blot analysis. The indolent clinical course of the cutaneous disease, and the low and stable number of circulating neoplastic T cells supported the diagnosis of a mycosis fungoides (MF)-like PTCL. Possible oncogenic events and/or putative underlying viral infections which could have played a role in the occurrence of B- and T-cell non-Hodgkin's lymphomas in the same patient are discussed.


Subject(s)
Leukemia, B-Cell/complications , Leukemia, Hairy Cell/complications , Lymphoma, T-Cell, Cutaneous/complications , Skin Neoplasms/complications , Aged , Biopsy , Blotting, Southern , Bone Marrow/pathology , DNA/blood , Female , Humans , Immunophenotyping , Skin/pathology
14.
Blood Coagul Fibrinolysis ; 10(7): 439-42, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10695771

ABSTRACT

We report the case of a 65-year-old man affected by idiopathic thrombocytopenic purpura, who developed an acute myocardial infarction after 2 years of steroid therapy. Thrombocytopenia was initially recognized 11 years earlier, and became severe during the past 2 years [platelets (PLTS) 10000-30000/microl]. He was treated with steroids, initially to perform a surgical procedure (prednisone 75 mg/day), subsequently to maintain a platelet count of about 50000/microl (prednisone 12.5 mg/day). After 1 year of treatment, he began to complain about exertional angina and dyspnea. His blood pressure became elevated and cholesterol level raised. The exercise electrocardiogram, previously manifesting ischaemic changes, normalized after 1 month of steroid wash-out; however, steroid therapy was reinstituted (prednisone 5 mg per day). One year later, he suffered an infero-lateral non-Q-wave myocardial infarction. It seems likely that the severe coronary atherosclerosis present in our patient developed despite a low platelet count, under the spur of a heavier risk factor profile. Steroid therapy could have had a role as a precipitating agent of the acute event, and the opportunity of alternative treatments is considered.


Subject(s)
Myocardial Infarction/etiology , Purpura, Thrombocytopenic, Idiopathic/complications , Purpura, Thrombocytopenic, Idiopathic/drug therapy , Steroids/therapeutic use , Aged , Humans , Male , Myocardial Infarction/blood , Platelet Count , Purpura, Thrombocytopenic, Idiopathic/blood , Risk Factors
19.
Int J Artif Organs ; 18(9): 534-43, 1995 Sep.
Article in English | MEDLINE | ID: mdl-8582772

ABSTRACT

The aim of this study is to present a clinical experience carried out with a new device designed to measure on-line Urea Nitrogen concentration in the effluent dialysate. The Biostat 1000 Urea Monitor (Baxter Healthcare, Dirfield, Ill, USA) was utilized in the present study. The monitor is based on the principle that multiple urea measurements in the dialysate effluent from the dialyzer, permit to built a double exponential regression leading to the urea kinetic parameters of the dialysis session. Data obtained with the Urea Monitor were, in the present study, compared with those obtained by direct measurements carried out in blood and dialysate and by the collection of the whole amount of spent dialysate. The monitor provided an accurate value of predialysis BUN without any blood drawing. Urea kinetics were established from multiple dialysate measurements and no blood drawing was necessary. The double pool kinetics were taken into account and Kt/V, PCR and SRI% obtained were comparable to those obtained from direct measurement. Since a projected value of Kt/V can be obtained, the monitor could represent a potential source of information to detect possible filter and machine dysfunction, as well as high rate of recirculation.


Subject(s)
Online Systems/standards , Renal Dialysis/standards , Urea/blood , Adult , Aged , Blood Urea Nitrogen , Female , Guidelines as Topic , Humans , Kinetics , Male , Middle Aged , Monitoring, Physiologic
SELECTION OF CITATIONS
SEARCH DETAIL